These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33151412)

  • 1. Clinicopathologic and molecular features of six cases of phosphaturic mesenchymal tumor.
    Sun L; Dehner C; Kenney J; McNulty SM; Zhu X; Pfeifer JD; Maluf HM; Chrisinger JSA
    Virchows Arch; 2021 Apr; 478(4):757-765. PubMed ID: 33151412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphaturic mesenchymal tumor without osteomalacia: additional confirmation of the "nonphosphaturic" variant, with emphasis on the roles of FGF23 chromogenic in situ hybridization and FN1-FGFR1 fluorescence in situ hybridization.
    Sent-Doux KN; Mackinnon C; Lee JC; Folpe AL; Habeeb O
    Hum Pathol; 2018 Oct; 80():94-98. PubMed ID: 29514106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, morphological and immunohistochemical analysis of 13 cases of phosphaturic mesenchymal tumor - A holistic diagnostic approach.
    Chatterjee D; Bardia A; Pal R; Saikia UN; Bhadada SK; Radotra BD
    Ann Diagn Pathol; 2021 Oct; 54():151783. PubMed ID: 34329884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Klotho Overexpression Is Frequently Associated With Upstream Rearrangements in Fusion-Negative Phosphaturic Mesenchymal Tumors of Bone and Sinonasal Tract.
    Lee JC; Hsieh TH; Kao YC; Tsai CF; Huang HY; Shih CY; Song HL; Oda Y; Chih-Hsueh Chen P; Pan CC; Sittampalam K; Petersson F; Konishi E; Chiu WY; Chen CF; Carpenter TO; Lu TP; Chang CD; Huang SC; Folpe AL
    Mod Pathol; 2023 Dec; 36(12):100336. PubMed ID: 37742927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 50-Year-Old Man Presenting with Multiple Bone Lesions and a Diagnosis of Phosphaturic Mesenchymal Tumor of the Femur.
    Ren D; Wei K; Ifegwu I
    Am J Case Rep; 2024 Feb; 25():e942810. PubMed ID: 38361352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphaturic Mesenchymal Tumors: Clinicopathologic, Immunohistochemical and Molecular Analysis of 22 Cases Expanding their Morphologic and Immunophenotypic Spectrum.
    Agaimy A; Michal M; Chiosea S; Petersson F; Hadravsky L; Kristiansen G; Horch RE; Schmolders J; Hartmann A; Haller F; Michal M
    Am J Surg Pathol; 2017 Oct; 41(10):1371-1380. PubMed ID: 28614212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variant.
    Yamada Y; Kinoshita I; Kenichi K; Yamamoto H; Iwasaki T; Otsuka H; Yoshimoto M; Ishihara S; Toda Y; Kuma Y; Setsu N; Koga Y; Honda Y; Inoue T; Yanai H; Yamashita K; Ito I; Takahashi M; Ohga S; Furue M; Nakashima Y; Oda Y
    Histopathology; 2018 Feb; 72(3):460-471. PubMed ID: 28858396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphaturic Mesenchymal Tumor Involving the Head and Neck: A Report of Five Cases with FGFR1 Fluorescence In Situ Hybridization Analysis.
    Wasserman JK; Purgina B; Lai CK; Gravel D; Mahaffey A; Bell D; Chiosea SI
    Head Neck Pathol; 2016 Sep; 10(3):279-85. PubMed ID: 26759148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent overexpression of klotho in fusion-negative phosphaturic mesenchymal tumors with tumorigenic implications.
    Lee CH; Su SY; Sittampalam K; Chen PC; Petersson F; Kao YC; Carpenter TO; Hsieh TH; Konishi E; Tsai JW; Billings SD; Folpe AL; Lee JC
    Mod Pathol; 2020 May; 33(5):858-870. PubMed ID: 31792355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors.
    Lee JC; Su SY; Changou CA; Yang RS; Tsai KS; Collins MT; Orwoll ES; Lin CY; Chen SH; Shih SR; Lee CH; Oda Y; Billings SD; Li CF; Nielsen GP; Konishi E; Petersson F; Carpenter TO; Sittampalam K; Huang HY; Folpe AL
    Mod Pathol; 2016 Nov; 29(11):1335-1346. PubMed ID: 27443518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour.
    Lee JC; Jeng YM; Su SY; Wu CT; Tsai KS; Lee CH; Lin CY; Carter JM; Huang JW; Chen SH; Shih SR; Mariño-Enríquez A; Chen CC; Folpe AL; Chang YL; Liang CW
    J Pathol; 2015 Mar; 235(4):539-45. PubMed ID: 25319834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).
    Houang M; Clarkson A; Sioson L; Elston MS; Clifton-Bligh RJ; Dray M; Ranchere-Vince D; Decouvelaere AV; de la Fouchardiere A; Gill AJ
    Hum Pathol; 2013 Dec; 44(12):2711-8. PubMed ID: 24060005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphaturic Mesenchymal Tumors in the Head and Neck Demonstrate a Broad Clinical and Morphologic Spectrum.
    Hulme KR; Mahar A; Campbell RG; Clifton-Bligh R; Gill AJ; Palme CE; Gupta R
    Head Neck Pathol; 2022 Sep; 16(3):902-912. PubMed ID: 35119617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?
    Ledford CK; Zelenski NA; Cardona DM; Brigman BE; Eward WC
    Clin Orthop Relat Res; 2013 Nov; 471(11):3618-25. PubMed ID: 23868423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-induced osteomalacia: An overview.
    Jadhav SS; Shah R; Patil V
    Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101834. PubMed ID: 37935612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hiding in plain sight: Gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosphatemia.
    Colazo JM; DeCorte JA; Gillaspie EA; Folpe AL; Dahir KM
    Bone Rep; 2021 Jun; 14():100744. PubMed ID: 33490314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytological findings of phosphaturic mesenchymal tumor: Report of a case with summary of prior published cases.
    Das O; Mohin M; Dey S; Kar A; Singhania P; Adhikari S; Chowdhury S; Chatterjee U
    Diagn Cytopathol; 2024 Feb; 52(2):E44-E47. PubMed ID: 37897246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From epistaxis to bone pain-report of two cases illustrating the clinicopathological spectrum of phosphaturic mesenchymal tumour with fibroblast growth factor receptor 1 immunohistochemical and cytogenetic analyses.
    Mok Y; Lee JC; Lum JH; Petersson F
    Histopathology; 2016 May; 68(6):925-30. PubMed ID: 26407099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphaturic mesenchymal tumor: A chondromyxoid fibroma-like type.
    Koga K; Iwasaki H; Nabeshima K
    J Dermatol; 2023 Nov; 50(11):1484-1487. PubMed ID: 37350024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia.
    Abate V; Vergatti A; De Filippo G; Damiano V; Menale C; D'Elia L; Rendina D
    J Clin Endocrinol Metab; 2024 Feb; 109(3):e1006-e1011. PubMed ID: 38006315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.